SCHEMBL27984643

SCHEMBL27984643

Fc1ccc(-c2ncc3c(n2)CCCC3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.44
TNKS2 Q9H2K2 1/20 0.44
HTR2B P41595 2/20 0.43
KMT2A Q03164 2/20 0.42
CDK5 Q00535 5/20 0.42
CDK5R1 Q15078 5/20 0.42
HDAC9 Q9UKV0 1/20 0.41
CCNA2 P20248 4/20 0.40
CDK2 P24941 4/20 0.40
GRM5 P41594 2/20 0.40
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.38
PIKFYVE Q9Y2I7 1/20 0.38
MAOB P27338 1/20 0.37
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2977002 0.80 CDK5 (0.38) HTR2CHTR2BKMT2ACDK5CDK5R1
SCHEMBL11183504 0.76 MAOA (0.41) HTR2CTNKS2HDAC9GRM5MAOB
SCHEMBL19674746 0.76 MAPT (0.43)
SCHEMBL22322760 0.75 HTR2C (0.43) HTR2CTNKS2CDK5CDK5R1CCNA2
SCHEMBL9959918 0.73 CDK5 (0.74) KMT2ACDK5CDK5R1CCNA2CDK2
SCHEMBL11176219 0.73 TNKS2 (0.36) HTR2CTNKS2HTR2BHDAC9GRM5
SCHEMBL27999602 0.72 MAPK1 (0.45) KMT2AMEN1NPC1RAB9AATM
SCHEMBL3869454 0.72 KMT2A (0.41) HTR2CKMT2AGRM5HDAC1HDAC2
SCHEMBL716608 0.72 KMT2A (0.52) HTR2CHTR2BKMT2AGRM5NPC1
SCHEMBL11188997 0.71 HDAC9 (0.37) HTR2CTNKS2HTR2BHDAC9GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103328451-B Compounds for the reduction of beta-amyloid production BRISTOL MYERS SQUIBB CO 2015-06-10 CN disclosed
CN-102548557-B Compounds for reducing beta-amyloid production BRISTOL MYERS SQUIBB CO 2014-12-24 CN disclosed